Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RELN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RELN is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, protects against, implicated in. Associated with AD, AMI, Aging. Connected to 82 entities in the SciDEX knowledge graph.
| Gene Symbol | RELN |
| Full Name | Reelin |
| Chromosome | 7q22.1 |
| Protein Type | Signaling Protein |
| Target Class | Signaling Protein |
| Function | The protein contains an N-terminal signal peptide followed by 8 reelin repeat domains (R1-R8), each approximately 350 amino acids in length. |
| Mechanism of Action | Drugs targeting RELN would primarily work by enhancing reelin expression or signaling through its receptors (VLDLR and ApoER2) to promote neuronal migration, synaptic plasticity, and cognitive function. Alternatively, pathway modulators could enhance downstream signaling cascades (Dab1-mediated pathways) to compensate for reelin deficiency or dysfunction. |
| Primary Expression | migrating neurons and mature neurons, VLDLR mediates reelin signaling involved in neuronal positioning and synaptic function [4](https://pubmed |
| Druggability | Low (0.33) |
| Clinical Stage | Approved |
| Molecular Weight | 400 kDa |
| Amino Acids | 350 aa |
| Pathways | Epigenetic, Reelin-Mediated Cytoskeletal Stabilization Protoco |
| UniProt ID | P78509 |
| Ensembl ID | ENSG00000189056 |
| GeneCards | RELN |
| Human Protein Atlas | RELN |
| Associated Diseases | AD, ALS, AMI, Alzheimer, Alzheimer disease |
| Known Drugs/Compounds | valproic acid |
| Interactions | DNMT1, DNMT3B, BDNF, DAB1, PSEN1, TAU |
| SciDEX Target | View Target Profile (9 clinical trials) |
| SciDEX Hypotheses | Reelin-Mediated Cytoskeletal Stabilization Protoco |
| KG Connections | 253 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
RELN["RELN"] -->|"regulates"| Reelin_Mediated_Cytoskeletal_S["Reelin-Mediated Cytoskeletal Stabilization Protoco"]
RELN["RELN"] -->|"protects against"| Alzheimer["Alzheimer"]
RELN["RELN"] -->|"regulates"| Neurodegeneration["Neurodegeneration"]
RELN["RELN"] -->|"interacts"| Schizophrenia["Schizophrenia"]
RELN["RELN"] -->|"therapeutic target"| Dementia["Dementia"]
RELN["RELN"] -->|"interacts"| Alzheimer_1["Alzheimer"]
h_d2df6eaf["h-d2df6eaf"] -->|"therapeutic target"| RELN["RELN"]
h_d2df6eaf_2["h-d2df6eaf"] -->|"targets"| RELN["RELN"]
JUN["JUN"] -->|"protects against"| RELN["RELN"]
APOE["APOE"] -->|"associated"| RELN["RELN"]
style RELN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| DENDRITIC GROWTH | regulates | entity | 0.95 |
| DENDRITIC SPINE FORMATION | regulates | entity | 0.95 |
| SYNAPTOGENESIS | regulates | entity | 0.95 |
| VLDLR | binds_to | entity | 0.95 |
| APOE | binds_to | entity | 0.95 |
| VLDLR | binds | protein | 0.95 |
| Apoer2 | binds | protein | 0.95 |
| superficial dorsal horn | expressed_in | brain_region | 0.95 |
| NEURONAL MIGRATION | regulates | entity | 0.95 |
| SYNAPTIC PLASTICITY | regulates | entity | 0.95 |
| dendritic growth and branching | regulates | process | 0.90 |
| DAB1 | interacts_with | protein | 0.90 |
| neuron positioning in dorsal horn | regulates | process | 0.90 |
| neuronal lamination | regulates | process | 0.90 |
| ALZHEIMER'S DISEASE | associated_with | entity | 0.90 |
| ALZHEIMER'S DISEASE | implicated_in | entity | 0.90 |
| Heart Development | involved_in | process | 0.85 |
| Heart Injury Repair | involved_in | process | 0.85 |
| Neuronal Architecture Formation | regulates | process | 0.85 |
| dI5 neuron migration | mediates | process | 0.85 |
| synaptic function | regulates | process | 0.85 |
| Lissencephaly | associated_with | disease | 0.85 |
| AUTISM | implicated_in | entity | 0.85 |
| SCHIZOPHRENIA | implicated_in | entity | 0.85 |
| BIPOLAR DISORDER | implicated_in | entity | 0.85 |
| DEPRESSION | implicated_in | entity | 0.85 |
| EPILEPSY | implicated_in | entity | 0.85 |
| Alzheimer'S Disease | protects_against | disease | 0.85 |
| Alzheimer'S Disease | risk_factor_for | disease | 0.85 |
| Lissencephaly | causes | disease | 0.80 |
| disease progression | modulates | phenotype | 0.80 |
| lamina V | contributes_to | brain_region | 0.80 |
| lamina I positioning defect | implicated_in | phenotype | 0.80 |
| regenerative response | drives | process | 0.80 |
| CORTEX | expressed_in | entity | 0.80 |
| HIPPOCAMPUS | expressed_in | entity | 0.80 |
| Alzheimer'S Disease | associated_with | disease | 0.80 |
| reelin_protein | encodes | protein | 0.80 |
| heart development | regulates | process | 0.75 |
| microglia regenerative response | upregulates | process | 0.75 |
| Reelin-Mediated Cytoskeletal Stabilization Protoco | regulates | mechanism | 0.70 |
| injury repair | promotes | process | 0.70 |
| Alzheimer's Disease | risk_factor_for | disease | 0.70 |
| anti-HSV1-gD antibody levels | modulates | phenotype | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Schizophrenia | interacts_with | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CDH5 | regulates | protein | 0.95 |
| SRC | interacts_with | entity | 0.90 |
| FYN | interacts_with | entity | 0.90 |
| CDH5 | mediates | protein | 0.90 |
| h-d2df6eaf | targets_gene | hypothesis | 0.90 |
| h-d2df6eaf | targets | hypothesis | 0.80 |
| Km Allotype | interacts_with | biomarker | 0.75 |
| APOE | co_mentioned_with | gene | 0.60 |
| JUN | protects_against | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| DAB1 | interacts_with | gene | 0.60 |
| DHX9 | associated_with | gene | 0.60 |
| KCNT1 | therapeutic_target | gene | 0.60 |
| KCNQ2 | therapeutic_target | gene | 0.60 |
| SCN1A | therapeutic_target | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| APOE4 | associated_with | gene | 0.60 |
| REELIN | protects_against | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| DAB1 | activates | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| REELIN | activates | gene | 0.60 |
| LDLR | interacts_with | gene | 0.60 |
| valproic acid | activates | compound | 0.60 |
| valproic acid | inhibits | compound | 0.60 |
| APOE | protects_against | gene | 0.60 |
| CAV1 | associated_with | gene | 0.60 |
| CAV1 | interacts_with | gene | 0.60 |
| CAV1 | implicated_in | gene | 0.60 |
| APOE | biomarker_for | gene | 0.60 |
| CLU | biomarker_for | gene | 0.60 |
| KM | interacts_with | phenotype | 0.60 |
| APOE | interacts_with | gene | 0.60 |
| ATP8B1 | interacts_with | gene | 0.60 |
| CLU | interacts_with | gene | 0.60 |
| NPTX2 | interacts_with | gene | 0.60 |
| PICALM | interacts_with | gene | 0.60 |
| PLCG2 | interacts_with | gene | 0.60 |
| RAB10 | interacts_with | gene | 0.60 |
| MET | activates | gene | 0.60 |
| CAV1 | targets | gene | 0.60 |
| NME1 | targets | gene | 0.60 |
| NME1 | interacts_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| MIRNAS | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| PHAGOCYTOSIS | protects_against | gene | 0.60 |
| ALZHEIMER'S DISEASE | protects_against | gene | 0.60 |
| MICROGLIA | protects_against | gene | 0.60 |
| ALZHEIMER | protects_against | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Reelin-Mediated Cytoskeletal Stabilization Protocol | 0.448 | neurodegeneration | Selective vulnerability of entorhinal co |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.484
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunction. [PMID:39892386] | Vandal M, Institoris A, Reveret L, Korin | Neuron | 2025 | 1 |
| Protective genetic variants against Alzheimer's disease. [PMID:40409316] | Marino C, Malotaux V, Giudicessi A, Agui | Lancet Neurol | 2025 | 1 |
| Proximity interactome of lymphatic VE-cadherin reveals mechanisms of junctional [PMID:39232006] | Serafin DS, Harris NR, Bálint L, Douglas | Nat Commun | 2024 | 1 |
| Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Devel [PMID:32604886] | Jossin Y | Biomolecules | 2020 | 1 |
| Neuronal migration. [PMID:11429281] | Lambert de Rouvroit C, Goffinet AM | Mech Dev | 2001 | 1 |
| Modulation of apolipoprotein E receptor-2 by ApoE4, amyloid β-peptide, reelin, a [PMID:41858499] | ["Barger S", "Moerman-Herzog A"] | Frontiers in molecular neurosc | 2026 | 0 |
| The Potential Molecular Mechanisms and Key Genes of Early Deterioration of Paren [PMID:41863408] | ["Cen G", "Li J", "Wang J", "Chen Y", "L | Current neurovascular research | 2026 | 0 |
| RELN biallelic variant as a candidate risk factor in a consanguineous Pakistani [PMID:41785923] | ["Hashmi A", "Harripaul R", "Muhammad T" | Journal of affective disorders | 2026 | 0 |
| Temporal and Spatial Gene Expression Dynamics in Neonatal HI Hippocampus with Fo [PMID:41677619] | ["Smith M", "Natarajan E", "Lizama-Valen | Cells | 2026 | 0 |
| Migration of dI5 Reelin-Lmx1b-Zfhx3 and Disabled-1-Lmx1b-Zfhx3 neurons contribut [PMID:41890024] | ["Yvone G", "Chavez-Martinez C", "Mekonn | bioRxiv : the preprint server | 2026 | 0 |
| Whisking Behaviour Reveals Stronger Evidence of Habituation in Homozygous Reeler [PMID:41844513] | ["Simanaviciute U", "Cetin A", "Guy J", | Genes, brain, and behavior | 2026 | 0 |
| Reln haploinsufficiency enhances fentanyl-induced locomotion and striatal activi [PMID:41890027] | ["Litif C", "Libster A", "Desfor S", "Hu | bioRxiv : the preprint server | 2026 | 0 |
| Immunoglobulin allotypes and [PMID:41848375] | ["Pandey J", "Namboodiri A", "Nietert P" | Journal of Alzheimer's disease | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | ["Burdman G", "Akkaoui J", "Colon N", "P | Neurology international | 2026 | 0 |
| Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improve [PMID:40073057] | ["Calvier L", "Wasser C", "Solow E", "Wu | Proceedings of the National Ac | 2025 | 0 |
| Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheime [PMID:41035073] | Castanho I, Naderi Yeganeh P, Boix CA, M | Molecular neurodegeneration | 2025 | 0 |
| Glutamatergic argonaute2 promotes the formation of the neurovascular unit in mic [PMID:39999211] | Sona C, Yeh YT, Li Y, Liu X, Ghosh A, Hi | Science signaling | 2025 | 0 |
| APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodege [PMID:40307424] | ["Vanherle S", "Janssen A", "Guti\u00e9r | Molecular psychiatry | 2025 | 0 |
| Protective Genes Against Alzheimer's Disease: Case Review and Therapeutic Implic [PMID:40321438] | Hossain N, Jeong Y | Dementia and neurocognitive di | 2025 | 0 |
| Biomolecular Aspects of Reelin in Neurodegenerative Disorders: An Old Candidate [PMID:40806482] | Balzamino BO, Biamonte F, Micera A | International journal of molec | 2025 | 0 |